Genscript Biotech Corporation

SHSC:1548 Stock Report

Market Cap: HK$20.9b

Genscript Biotech Management

Management criteria checks 1/4

Genscript Biotech's CEO is Weihui Shao, appointed in Jul 2021, has a tenure of 3.42 years. total yearly compensation is $2.48M, comprised of 14.3% salary and 85.7% bonuses, including company stock and options. directly owns 0.034% of the company’s shares, worth HK$6.99M. The average tenure of the management team and the board of directors is 3.7 years and 1.8 years respectively.

Key information

Weihui Shao

Chief executive officer

US$2.5m

Total compensation

CEO salary percentage14.3%
CEO tenure3.4yrs
CEO ownership0.03%
Management average tenure3.7yrs
Board average tenure1.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Weihui Shao's remuneration changed compared to Genscript Biotech's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-US$177m

Mar 31 2024n/an/a

-US$136m

Dec 31 2023US$2mUS$353k

-US$95m

Compensation vs Market: Weihui's total compensation ($USD2.48M) is above average for companies of similar size in the Hong Kong market ($USD471.04K).

Compensation vs Earnings: Insufficient data to compare Weihui's compensation with company performance.

CEO

Weihui Shao (44 yo)

3.4yrs

Tenure

US$2,477,000

Compensation

Ms. Weihui Shao is Chief Operating Officer of Genscript Biotech Corporation from July 08, 2021 and serves as its Rotating Chief Executive Officer since January 01, 2023. She joined the Genscript Biotech Co...

Leadership Team

NamePositionTenureCompensationOwnership
Jiange Meng
Executive Chairman9.3yrsUS$495.00k0.013%
HK$ 2.7m
Weihui Shao
CEO & COO3.4yrsUS$2.48m0.034%
HK$ 7.0m
Ye Wang
Co-Founder22.9yrsUS$659.00k0.038%
HK$ 7.9m
Luquan Wang
Co-Founder & Non-Executive Directorno datano data0.030%
HK$ 6.2m
Fangliang Zhang
Co-Founder & Executive Director2yrsUS$531.00kno data
Li Zhu
Chief Strategy Officer & Executive Director4.1yrsUS$320.00k0.053%
HK$ 11.1m
Shiniu Wei
Chief Financial Officer4yrsno datano data
Aylin Bilgin
Chief Marketing Officer for GenScript Life Science Groupless than a yearno datano data

3.7yrs

Average Tenure

56yo

Average Age

Experienced Management: 1548's management team is considered experienced (3.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Jiange Meng
Executive Chairman9.3yrsUS$495.00k0.013%
HK$ 2.7m
Ye Wang
Co-Founder9.6yrsUS$659.00k0.038%
HK$ 7.9m
Luquan Wang
Co-Founder & Non-Executive Director9.6yrsno data0.030%
HK$ 6.2m
Fangliang Zhang
Co-Founder & Executive Director2.6yrsUS$531.00kno data
Li Zhu
Chief Strategy Officer & Executive Director4.1yrsUS$320.00k0.053%
HK$ 11.1m
Carl June
Member of Advisory Boardless than a yearno datano data
George Church
Member of Advisory Board5.3yrsno datano data
Alphonse Galdes
Independent Non-Executive Directorless than a yearno datano data
David Liu
Member of Scientific Advisory Boardless than a yearno datano data
Yiu Leung Cheung
Independent Non-Executive Directorless than a yearno datano data
Chenyang Shi
Independent Non-Executive Directorless than a yearno datano data
Ethan Pan
Independent Non-Executive Directorless than a yearno datano data

1.8yrs

Average Tenure

61.5yo

Average Age

Experienced Board: 1548's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 20:42
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Genscript Biotech Corporation is covered by 21 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Linda LuBOCI Research Ltd.
Jin ZhangChina International Capital Corporation Limited
Yue-Kwong LuiChina Renaissance Securities